Reata Pharmaceuticals, Inc.
RETA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $42 | $590 | $818 | $664 |
| Short-Term Investments | $345 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $10 | $6 | $29 | $5 |
| Total Curr. Assets | $398 | $596 | $847 | $669 |
| Property Plant & Equip (Net) | $116 | $138 | $5 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $5 | $10 |
| Total NC Assets | $117 | $139 | $10 | $13 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $514 | $735 | $858 | $682 |
| Liabilities | – | – | – | – |
| Payables | $19 | $14 | $5 | $2 |
| Short-Term Debt | $2 | $3 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $2 | $5 | $5 |
| Other Curr. Liab. | $38 | $36 | $110 | $185 |
| Total Curr. Liab. | $59 | $54 | $119 | $192 |
| LT Debt | $117 | $133 | $0 | $155 |
| Deferred Rev, NC | $0 | $0 | $5 | $9 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $62 |
| Other NC Liab. | $404 | $362 | $316 | $74 |
| Total NC Liab. | $521 | $495 | $321 | $234 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $580 | $549 | $440 | $426 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,568 | -$1,256 | -$958 | -$710 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $1,502 | -$0 | -$0 | -$0 |
| Total Equity | -$66 | -$1,256 | -$958 | -$710 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $514 | -$707 | -$518 | -$285 |
| Net Debt | $77 | -$454 | -$818 | -$509 |